Microsoft shares jump after fourth-quarter earnings beat on AI-fueled cloud growth
Investing.com -- Gerresheimer AG (BS:GXId), a German company that manufactures packaging for drugs and cosmetics, is said to be considering a sale amid interest from private equity firms, according to a report Friday from Bloomberg, citing people with knowledge of the matter.
The Dusseldorf-based company is working with advisors to evaluate interest from potential buyers. Over the past year, Gerresheimer’s shares have decreased by 23%, resulting in a market value of approximately €2.5 billion ($2.6 billion).
Private equity firms Warburg Pincus, EQT AB (ST:EQTAB), and KKR & Co (NYSE:KKR). are among the interested parties that have been studying the business, the report noted. Gerresheimer has been seen as an attractive acquisition target for buyout firms due to the different nature of its two businesses. However, several private equity funds have decided not to pursue a deal at the company’s current valuation.
In addition to considering a sale of the entire company, Gerresheimer has also been exploring strategic options for its molded glass business since last year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.